Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

Efficacy of Surgery for Idiopathic Toe Walking

Recruiting

Conditions: Idiopathic Toe-walking

Interventions: Procedure: Achilles Lengthening Surgery

First Posted Date: 2024-09-24

Last Posted Date: 2024-09-24

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT06610591

Locations: 🇬🇧
St George's University Hospitals NHS Foundation Trust, Tooting, London, United Kingdom
🇬🇧
Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, United Kingdom

Defining, Recognising and Escalating Maternal Early Deterioration (DREaMED)

Active, not recruiting

Conditions: Pregnancy, High Risk
Pregnancy Complications

First Posted Date: 2024-08-19

Last Posted Date: 2024-08-29

Lead Sponsor: University of Oxford

Target Recruit Count: 459160

Registration Number: NCT06560931

Locations: 🇬🇧
Critical Care Research Group, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, Oxfordshire, United Kingdom

Nitrous Oxide and EMOtional Cognition

Not Applicable

Recruiting

Conditions: Depression

Interventions: Drug: Entonox
Drug: Medical Air

First Posted Date: 2024-08-16

Last Posted Date: 2024-08-29

Lead Sponsor: University of Oxford

Target Recruit Count: 84

Registration Number: NCT06557642

Locations: 🇬🇧
Psychiatry Department, Oxford, United Kingdom

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Phase 1

Not yet recruiting

Conditions: Plasmodium Falciparum Malaria

Interventions: Biological: Pfs25-IMX313, Pfs48/45

First Posted Date: 2024-08-12

Last Posted Date: 2025-05-21

Lead Sponsor: University of Oxford

Target Recruit Count: 56

Registration Number: NCT06549257

Lung Innate Immunity and Microbiome After Tuberculosis Exposure

Recruiting

Conditions: Tuberculosis
Latent Tuberculosis

First Posted Date: 2024-07-30

Last Posted Date: 2025-01-22

Lead Sponsor: University of Oxford

Target Recruit Count: 50

Registration Number: NCT06526689

Locations: 🇬🇧
Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxon, United Kingdom
🇬🇧
Grove Building, Royal Free NHS Foundation Trust, London, United Kingdom

The Oxford Pleural Infection Endotyping Study

Completed

Conditions: Pleural Infection
Pleural Diseases
Pleural Infections and Inflammations
Pleural Empyema
Pleural Infection Bacterial
Pleural Effusion

First Posted Date: 2024-07-22

Last Posted Date: 2024-07-22

Lead Sponsor: University of Oxford

Target Recruit Count: 80

Registration Number: NCT06513689

Locations: 🇬🇧
Laboratory of Pleural Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, Oxfordshire, United Kingdom

Assessing Antiviral Treatments in Early Symptomatic RSV

Phase 2

Recruiting

Conditions: Respiratory Syncytial Virus, Human
Respiratory Syncytial Virus

Interventions: Drug: Ribavirin
Drug: Favipiravir
Drug: Molnupiravir

First Posted Date: 2024-07-05

Last Posted Date: 2025-07-02

Lead Sponsor: University of Oxford

Target Recruit Count: 1000

Registration Number: NCT06488300

Locations: 🇱🇦
Laos-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic
🇹🇭
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand

Frontosubthalamic Networks in Parkinson's Disease.

Not Applicable

Recruiting

Conditions: Parkinson Disease
Impulse Control Disorder

Interventions: Other: DBS on/off

First Posted Date: 2024-07-03

Last Posted Date: 2025-04-02

Lead Sponsor: University of Oxford

Target Recruit Count: 20

Registration Number: NCT06485986

Locations: 🇬🇧
John Radcliffe Hospital, Oxford, United Kingdom

Glutamate Activity in Depression (GLADE)

Not Applicable

Not yet recruiting

Conditions: Depression

Interventions: Other: Flickering Checkerboard Stimulation

First Posted Date: 2024-07-01

Last Posted Date: 2024-07-01

Lead Sponsor: University of Oxford

Target Recruit Count: 40

Registration Number: NCT06482606

Locations: 🇬🇧
University of Oxford, Oxford, Oxfordshire, United Kingdom

COV-CHIM02: SARS-CoV-2 Omicron BA.5 Subvariant Dose Finding Infection Study

Phase 1

Recruiting

Conditions: SARS-CoV-2 Infection

Interventions: Biological: Omicron BA.5 SARS-CoV-2 challenge virus

First Posted Date: 2024-06-27

Last Posted Date: 2024-06-27

Lead Sponsor: University of Oxford

Target Recruit Count: 45

Registration Number: NCT06478420

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, Oxford, Oxfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy